Polarean Imaging PLC shares jumped on Friday after it unveiled a collaboration with Philips to advance the field of hyperpolarised Xenon MRI.

Polarean is a London-based medical imaging technology company and Philips is a Dutch conglomerate with a health technology division.

Philips will showcase its 3T MR 7700 system, featuring fully integrated multi-nuclei imaging, including Polarean’s Xenoview technology at the 2023 International Society for Magnetic Resonance in Medicine Annual Meeting & Exhibition, held from June 3 to 8, in Toronto, Canada.

This non-exclusive collaboration facilitates the sharing of technical data and marketing materials to jointly advance the field of Xenon MRI into the clinical realm.

It aims to deliver an advanced solution for the evaluation of lung ventilation in patients 12 years of age and older based on Xenon gas MR imaging, providing clinicians with enhanced productivity and image quality improvements.

Combining Xenoview with Philips MR 7700 multi-nuclei MRI scanner may allow clinicians to view a patient’s lungs in greater detail, while also enabling them to accurately measure lung ventilation, Polarean said.

This has the potential to make the difference between early diagnosis and intervention in serious obstructive lung diseases.

Richard Hullihen, chief executive of Polarean, said: ‘By deploying this novel technology to visualize otherwise unobtainable clinical information using MRI technology, MR imaging can now be expanded into pulmonary medicine, providing a quantitative tool to help clinicians and the patients they treat.’

Shares in Polarean jumped 10% to 27.00 pence in London on Friday.

Copyright 2023 Alliance News Ltd. All Rights Reserved.